McKesson Retained Earnings (Accumulated Deficit) 2010-2024 | MCK

McKesson retained earnings (accumulated deficit) from 2010 to 2024. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.
  • McKesson retained earnings (accumulated deficit) for the quarter ending September 30, 2024 were $15.959B, a 15.97% increase year-over-year.
  • McKesson retained earnings (accumulated deficit) for 2024 were $14.978B, a 21.82% increase from 2023.
  • McKesson retained earnings (accumulated deficit) for 2023 were $12.295B, a 36.16% increase from 2022.
  • McKesson retained earnings (accumulated deficit) for 2022 were $9.03B, a 10.1% increase from 2021.
McKesson Annual Retained Earnings (Accumulated Deficit)
(Millions of US $)
2024 $14,978
2023 $12,295
2022 $9,030
2021 $8,202
2020 $13,022
2019 $12,409
2018 $12,986
2017 $13,189
2016 $8,360
2015 $12,705
2014 $11,453
2013 $10,402
2012 $9,451
2011 $8,250
2010 $7,236
2009 $6,103
McKesson Quarterly Retained Earnings (Accumulated Deficit)
(Millions of US $)
2024-09-30 $15,959
2024-06-30 $15,810
2024-03-31 $14,978
2023-12-31 $14,268
2023-09-30 $13,761
2023-06-30 $13,182
2023-03-31 $12,295
2022-12-31 $11,582
2022-09-30 $10,579
2022-06-30 $9,732
2022-03-31 $9,030
2021-12-31 $8,734
2021-09-30 $8,812
2021-06-30 $8,618
2021-03-31 $8,202
2020-12-31 $7,595
2020-09-30 $13,890
2020-06-30 $13,384
2020-03-31 $13,022
2019-12-31 $12,075
2019-09-30 $11,965
2019-06-30 $12,770
2019-03-31 $12,409
2018-12-31 $13,276
2018-09-30 $13,354
2018-06-30 $12,932
2018-03-31 $12,986
2017-12-31 $14,202
2017-09-30 $13,370
2017-06-30 $13,442
2017-03-31 $13,189
2016-12-31 $9,663
2016-09-30 $9,088
2016-06-30 $8,843
2016-03-31 $8,360
2015-12-31 $7,995
2015-09-30 $13,780
2015-06-30 $13,227
2015-03-31 $12,705
2014-12-31 $12,628
2014-09-30 $12,211
2014-06-30 $11,800
2014-03-31 $11,453
2013-12-31 $11,138
2013-09-30 $11,130
2013-06-30 $10,780
2013-03-31 $10,402
2012-12-31 $10,384
2012-09-30 $10,135
2012-06-30 $9,783
2012-03-31 $9,451
2011-12-31 $8,981
2011-09-30 $8,731
2011-06-30 $8,486
2011-03-31 $8,250
2010-12-31 $7,876
2010-09-30 $7,767
2010-06-30 $7,488
2010-03-31 $7,236
2009-12-31 $6,921
2009-09-30 $6,627
2009-06-30 $6,358
2009-03-31 $6,103
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $79.753B $308.951B
McKesson Corporation is a health care services and information technology company. McKesson operates through two segments: The Distribution Solutions segment distributes branded and generic pharmaceutical drugs along with other healthcare-related products on a global basis worldwide. The segment also provides practice management, technology, clinical support and business solutions to community-based oncology and other specialty practices. In addition, the segment provides specialty pharmaceutical solutions for pharmaceutical manufacturers including offering multiple distribution channels and study access to oncology physicians. The Technology Solutions segment provides enterprise-wide clinical, patient care, financial, supply chain, and strategic management software solutions. per segment realignment, McKesson reported revenues through four segments: U.S. Pharmaceutical and Specialty Solutions, Internation, Medical-Surgical Solutions and Prescription Technology Solutions.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $65.165B 17.13
Cardinal Health (CAH) United States $29.869B 16.20
West Pharmaceutical Services (WST) United States $23.239B 47.47
Labcorp (LH) United States $20.088B 16.66
Cooper (COO) United States $19.898B 28.32
Align Technology (ALGN) United States $17.037B 32.60
Henry Schein (HSIC) United States $9.198B 17.52
Merit Medical Systems (MMSI) United States $6.121B 31.26
DENTSPLY SIRONA (XRAY) United States $3.705B 10.08
CONMED (CNMD) United States $2.215B 18.48
Patterson (PDCO) United States $1.788B 9.43
STAAR Surgical (STAA) United States $1.312B 48.42
Lifevantage (LFVN) United States $0.165B 21.93
Pro-Dex (PDEX) United States $0.138B 27.49